NYSEARCA:XHE - NYSE Arca - US78464A5810 - ETF - Currency: USD
Analyst upgrades Haemonetics to Buy, believes company can reach high-20% operating margin goal by FY26 through product mix analysis. Price target set at $112.
The medical equipment industry was hit hard when the treatment of COVID-19 cases became a priority for hospitals last year. However, the industry is mounting a solid recovery this year, with patients rescheduling their medical procedures. So, we think it could be wise to bet now on quality medical equipment stocks Conformis (CFMS), Harvard Bioscience (HBIO), and Accuray (ARAY), which are currently trading at affordable prices. Read on.
The medical devices industry has been performing remarkably well over the past year. And we think this trend will likely continue, driven by rising demand for non-emergency medical procedures and tech integration. Thus, quality medical device stocks ResMed Inc. (RMD), Alcon Inc. (ALC), Terumo Corp (TRUMY), and West Pharmaceuticals (WST) should gain substantially. So, let’s take a closer look at these names.
The medical equipment industry has been growing at a healthy clip this year, with rising demand for elective surgeries that had been on hold during the worst of the COVID-19 pandemic last year. So, two established medical equipment companies, Asensus (ASXC) and Surgaline (SRGA), should benefit in the coming months. But let’s see which of these two stocks is a better buy now.
Between the novel coronavirus and an election year, these healthcare ETFs appear poised to post strong growth into 2021.
MKM Partners writes that bullish technical signals abound for the sector.
Don't ignore healthcare stocks because 2020 is an election year. Some of these funds are poised for big upside.
Don't ignore healthcare stocks because 2020 is an election year. Some of these funds are poised for big upside.
SPDR S&P Health Care Equipment ETF (NYSEARCA:XHE) - $0.0032.Payable Dec 27; for shareholders of record Dec 24; ex-div Dec 23.
While traditional healthcare ETFs are not delivering jaw-dropping performances in the first quarter, there are some encouraging signs.
The healthcare sector has been heating up with merger frenzy that could change the landscape of healthcare business. Investors might want to tap into the space with the top-performing healthcare ETFs and stocks of 2018.
XHE is generally higher return than SPY and XLV, but is also more volatile. However, its Sharpe Ratio is competitive with the S&P 500.
Eight ETFs that have outperformed and gained more than 25% in the year-to-date time frame. These are also expected to continue outperforming, provided the fundamentals remain intact.
The exchange traded funds have more than tripled the returns of the S&P 500 this year.
Healthcare ETFs range from prosaic funds focusing on large-cap companies to funds offering access to fast-growing segments of the healthcare space. Here are 5 stellar options.
One of the best-performing corners of the health care sector this year is the medical device and equipment space, and total returns confirm the sentiment. The two exchange traded...
Mentions: XLV
Bernstein sees more gains for medical-device makers ahead.
Canaccord writes that the new Vets First Corp could add a diagnostics company to its portfolio.